EN PL
  1. www.sciencepharma.com
  2. News
  3. Regulatory and procedural guidance
  4. EMEA: Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man (CPMP/EWP/205/95 REV. 3) on Haematological malignancies

EMEA: Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man (CPMP/EWP/205/95 REV. 3) on Haematological malignancies

04.03.2010
The aim of this appendix is to provide guidance on the design of confirmatory in patients with haematological malignancies.
The source of the news: http://www.ema.europa.eu/pdfs/human/ewp/52008808enfin.pdf